Lupin gets USFDA nod for opioid analgesic tablets

New Delhi: Lupin Limited, a pharmaceutical company, has obtained its final approval from US Food and Drug Administration (USFDA) for its Oxycodone Hydrochloride tablets, which is u...

Sun Pharma receives USFDA nod for anti-cholesterol drug

New Delhi: Sun Pharmaceutical Industries has obtained the final approval from the US Food and Drug Administration (USFDA) for its generic version of ezetimibe tablets, which is used to reduce high ...

Strides Shasun gets USFDA nod for pain relieving drug

New Delhi: Strides Shasun Ltd has obtained the approval of the US Food and Drug Administration (USFDA) for its Amantadine Hydrochloride tablets, which is used in the treatment of P...

Eris Lifesciences plans to launch Rs 2,000 crore IPO in June

Mumbai: Indian pharmaceutical firm, Eric Lifesciences Pvt Ltd, is planning to launch its initial public offering (IPO) worth Rs 2,000 crore (US$ 310.46 million) by the end of June ...

Cadila Healthcare plans to raise Rs1,000 crore via QIP

Mumbai: Indian pharmaceutical company, Cadila Healthcare Ltd, is planning to raise Rs 1,000 crore (US$ 154.72 million) via a qualified institutional placement (QIP) of shares withi...

Jubilant Life gets USFDA nod for hypertension drug

New Delhi: Jubilant Life Sciences, a pharmaceutical company, has been granted a final approval from the US Food and Drug Administration for its olmesartan medoxomil tablets, that a...

Capital International buys 3% stake in Intas Pharmaceuticals for US$ 107 million

New Delhi: Capital International Group, a private equity fund, has acquired a three per cent stake in Intas Pharmaceuticals Ltd from ChrysCapital Llc for a consideration of US$ 107...

Aurobindo Pharma gets USFDA nod for Meropenem injection

New Delhi: Aurobindo Pharma has obtained an approval from the US Food & Drug Administration (USFDA) for its product, Meropenem injection, which is used for treatment of complic...